About Xihua Pharmaceutical:
Established in March 2021, Shanghai Xihua Pharmaceutical Co., LTD. has served nearly 600 Chinese and foreign customers with: API process research and development, analysis and development of large and small molecular and gene cell therapy products, innovative drug preparation research and development, clinical preparation production and commercial preparation production, drug administration declaration and CMC integrated research and development of CDMO technology and other services, including the top 50 pharmaceutical companies in China and most of the world’s top 10 pharmaceutical companies, as well as many other smaller Biotech ventures.
Our Solutions：
In order to improve the project development efficiency, and simplify the collection process of application documents, strengthen compliance control, to better serve customers. In 2023, Xihua Pharmaceutical and Neotrident Technology cooperate to use the advantages of SaaS cloud product to rapidly introduce a digital R&D data management platform consisted by: Project Management (PM), Electronic Lab Notebooks (ELN) and Chemical Inventory Management System (CIMS). Compared with the traditional localized deployment, all system modules of the iLabPower SaaS cloud platform have been already deployed on the cloud server, and it only takes a short period of time to complete the basic system settings and then put into use, which greatly saves the implementation cost, and the cost generated by the subsequent operation and maintenance of the hardware and software of the localized system, realizing lower cost, short time, high yield.
Results & Benefits：
Xihua Pharmaceutical uses the iLabPower PM project management system to breakdown tasks and milestones for each project，to achieve a refined project management, reducing project execution risks, and achieved a rapid delivery of results under the premise of ensuring compliance and product quality. At the same time, the project information is automatically pushed to the ELN and CIMS systems, so that all records and material usage are associated with the project information, and the data and material cost management in the project dimension are realized.
Using ELN’s experimental template, experimental cloning, mobile APP and other functions, simplify the experimental sorting process, and liberated scientists from the complicated record data sorting work. At the same time, ELN’s complete audit trail record and online record approval workflow for each record further strengthen the compliance management of Xihua Pharmaceutical’s R&D records.
Barcode material management is adopted to achieve accurate management of the whole life cycle of each bottle of material, while supporting online material inventory query, mobile APP QR code scaning for self-served claiming, and rapid import of material information into ELN records, which greatly improves the efficiency of laboratory material inventory management of Xihua Pharmaceutical.
With the help of iLabPower platform, Xihua Pharmaceutical has achieved:
- Standardized the project management process and realize real-time monitoring of the project and task process;
- Reducing project risks through budget and key node management;
- Experiment records and related documents are managed by the project dimension, which is convenient for the collation of project application materials;
- Standardized experimental records, with complete audit tracking of experimental records, and enhance compliance control;
- Achieving life-cycle management for chemicals and materials, automatically generate material ledger and statistical reports, avoid repeated procurement, reduce waste, and reduce laboratory costs;
